市場調査レポート

商品コード

インフルエンザワクチンの2028年までの市場予測-、ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別の世界的分析

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group

出版日: 2022年10月21日 | 発行: The Insight Partners

| ページ情報: 英文 209 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 713,258円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,778円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,340,298円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

インフルエンザワクチン市場は、2021年の74億7,853万米ドルから2028年には122億7,249万米ドルに成長すると予測されます。2022年から2028年までのCAGRは7.4%で成長すると予測されています。インフルエンザワクチン接種を促進するための政府支援の増加や、市場トップ企業や政府による投資の増加が、市場を押し上げる主な要因となっています。

各州の政府は、ワクチン接種プログラムの推進活動を支援しています。例えば、オーストラリア政府は、全国予防接種プログラム（NIP）を通じて、インフルエンザ関連の合併症のリスクがある人に季節性インフルエンザワクチンを無料で配布しています。2022年までに、NIPを通じて政府資金によるインフルエンザワクチンの接種対象となるすべてのリスクグループをカバーするのに十分な量のワクチンが接種される予定です。

以下は、インフルエンザワクチン接種に対する政府の支援を裏付けるいくつかの事例です。

2022年7月、フィロメナ・タッシ公共サービス・調達大臣とジャン＝イヴ・デュクロ保健大臣は、カナダ政府がグラクソ・スミスクライン（GSK）と新たな契約を結び、持続可能なインフルエンザのパンデミックレディネスを支援すると発表しました。カナダ政府は、インフルエンザが大流行した場合に備えて、パンデミックインフルエンザワクチンの準備態勢を維持しています。

2022年7月、オードリー・ゴードン保健大臣とスコット・ジョンストン長期介護大臣は、より多くのマニトバ州民がインフルエンザから守られるように、高用量インフルエンザワクチンの接種対象を65歳以上のすべての成人に拡大すると発表しました。

ビクトリア州政府は、2022年6月と7月までにGPと薬局がインフルエンザワクチンへのアクセスと摂取を改善するための助成金と払い戻しプログラムを受領しました。

2022年6月、ニュージーランド政府は、無料のインフルエンザワクチンへのアクセスを拡大し、2022年7月1日からニュージーランド人80万人が追加で対象となりました。3歳から12歳の子供と重度の精神衛生や中毒の問題を抱える人々が、インフルエンザワクチンの無料接種を受けられるようになりました。

台湾の疾病管理センター（台湾CDC）と厚生省は、2021年の政府資金によるインフルエンザ予防接種プログラムを開始するため、「一緒に健康を維持しましょう」と題したメディアイベントを開催しました。イベントでは、周局長、譚大使、蒋新氏が最初に接種を受け、政府資金によるインフルエンザワクチンの接種対象者に、プログラム終了後、できるだけ早くインフルエンザワクチンの接種を受けるよう呼びかけました。

2019年9月、ドナルド・トランプ米国大統領は、季節性インフルエンザおよびパンデミックインフルエンザ発生の可能性から保護するため、より優れたワクチンの開発を促進する大統領令に署名しました。

2021年10月、インフルエンザの季節が近づく中、州政府はニューファンドランド人とラブラドール人全員にインフルエンザの予防接種を受けるよう促していました。2021年10月25日から、地域保健当局（RHA）は無料のインフルエンザ予防接種クリニックの開催を開始しました。また、人々はかかりつけの医師や地元の薬局を通じてワクチンを接種することができます。このように、世界中でインフルエンザワクチン接種を促進するための政府支援の増加が、インフルエンザワクチン市場を牽引しています。

ワクチンタイプの洞察

ワクチンの種類に基づき、インフルエンザワクチン市場は4価ワクチンと3価ワクチンに区分されます。4価ワクチンセグメントは、2022年にはより大きな市場シェアを占めると思われます。同セグメントは、予測期間中に高いCAGRを記録すると予測されています。4価のインフルエンザワクチンは、2種類のA型インフルエンザウイルスと2種類のB型インフルエンザウイルスを含む4種類のインフルエンザウイルスから身を守ります。2021-2022年シーズンの米国におけるインフルエンザワクチンは、すべて4価ワクチンです。年齢層によって異なるワクチンが承認されています。

ウイルスタイプの洞察

ウイルスタイプに基づき、インフルエンザワクチン市場は、A型インフルエンザウイルスとB型インフルエンザウイルスに区分されます。同セグメントは予測期間中、より速いCAGRを記録すると予想されます。インフルエンザウイルスA型セグメントの市場成長は、このタイプのインフルエンザに関連する病気がより一般的であるにもかかわらず、インフルエンザの最も一般的な形態であり、動物に感染する可能性があるためです。

技術に関する洞察

インフルエンザワクチン市場は、技術に基づき、卵子ベースと細胞ベースに区分されます。2022年には、卵ベースのセグメントがより大きな市場シェアを占めると思われます。同セグメントは予測期間中、より速いCAGRを記録すると予想されます。卵ベースセグメントの市場成長は、70年以上にわたって使用されてきた卵ベースの製造プロセスを通じてインフルエンザワクチンを製造するという、最も一般的な方法によるものです。

投与経路の洞察

インフルエンザワクチン市場は、投与経路に基づき、注射剤と点鼻薬に区分されます。2022年には、注射剤がより大きな市場シェアを占めると予想されます。同セグメントは予測期間中、より高いCAGRを記録すると予想されます。注射剤セグメントの市場成長は、インフルエンザワクチン投与において最も一般的な方法であることに起因しています。

ターゲットグループの洞察

世界のインフルエンザワクチン市場は、ターゲットグループによって、乳幼児、小児、成人、高齢者に分けられます。2021年の市場では、乳幼児セグメントのシェアが大きくなっています。しかし、高齢者（老人）セグメントは予測期間中に最も高い成長率で成長すると予想されます。

国際貿易局（ITA）、Farmindustria-Bain &Company、EFPIA加盟団体、世界保健機関（WHO）、ビジネスモニターインターナショナル（BMI）、救急医学科、Indian Journal of Medical Sciencesなどは、インフルエンザワクチン市場に関するレポート作成時に参照した一次情報および二次情報の一部です。

調査範囲
インサイトパートナーズの調査報告書ガイダンス
市場セグメンテーション
- インフルエンザワクチンの世界市場：ワクチンタイプ別
- インフルエンザワクチンの世界市場：ウイルスタイプ別
- インフルエンザワクチンの世界市場：技術別
- インフルエンザワクチンの世界市場：投与経路別
- インフルエンザワクチンの世界市場：ターゲットグループ別
- インフルエンザワクチンの世界市場：地域別

第2章インフルエンザワクチン市場-主要なポイント

第3章調査手法

調査対象
2次調査
1次調査

第4章インフルエンザワクチン市場- 市場情勢

PEST分析
- 北米PEST分析
- 欧州PEST分析
- アジア太平洋地域のPEST分析
- 中東・アフリカPEST分析
- 中南米PEST分析
専門家の見解

第5章インフルエンザワクチンの世界市場- 主要な市場力学

市場促進要因
- インフルエンザワクチン接種を促進するための政府支援の増加
- トップ企業と政府別投資の増加
市場抑制要因
- ワクチン開発の高コスト
市場機会
- 新興国
今後の動向
- インフルエンザワクチンの強力なパイプライン候補
影響分析

第6章インフルエンザワクチン市場-世界分析

インフルエンザワクチンの世界市場：収益と予測・分析
インフルエンザワクチンの世界市場：地域別予測・分析
インフルエンザワクチンの世界市場：地域別市場ポテンシャル分析
企業分析
- 主要プレイヤーの市場ポジショニング
- 企業比較分析
成長戦略分析
主要プレイヤーの業績
- サノフィ
- セキラス

第7章インフルエンザワクチン市場の分析と2028年までの予測（ワクチンタイプ別）

インフルエンザワクチンの世界市場：ワクチンタイプ別2022年・2028年（%）
4価ワクチン
3価ワクチン

第8章インフルエンザワクチン市場の分析と2028年までの予測（ウイルスタイプ別）

インフルエンザワクチンの世界市場：ウイルスタイプ別2022 &2028（%）
インフルエンザウイルスA型
インフルエンザウイルスB型

第9章インフルエンザワクチン市場の分析と2028年までの予測（技術別）

インフルエンザワクチンの世界市場：技術別2022年 &2028年（%）
卵子ベース
細胞ベース

第10章インフルエンザワクチン市場の分析と2028年までの予測（投与経路別）

インフルエンザワクチンの世界市場：投与経路別2022 &2028（%）
注射剤
鼻腔用スプレー

第11章インフルエンザワクチン市場の分析と2028年までの予測（対象グループ別）

インフルエンザワクチンの世界市場：ターゲットグループ別2022年・2028年（%）
乳幼児
小児
成人
高齢者

第12章インフルエンザワクチン市場の分析と2028年までの予測（地域別分析）

北米
- 米国
- カナダ
- メキシコ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 中東・アフリカ地域
  - サウジアラビア
  - UAE
  - 南アフリカ
  - その他中東地域
- 中南米
  - ブラジル
  - アルゼンチン
  - その他の中南米地域

第13章 COVID-19パンデミックによるインフルエンザワクチンの世界市場への影響

北米
欧州
アジア太平洋地域
中東とアフリカ
中南米

第14章インフルエンザワクチン市場：業界情勢

インフルエンザワクチン市場の成長戦略、2021年～2028年
無機的な成長戦略
オーガニック成長戦略

第15章企業プロファイル

Moderna, Inc.
SEQIRUS
Sanofi
GlaxoSmithKline plc.
Hualan Biological Engineering Inc.
Emergent BioSolutions Inc.
Mitsubishi Chemical Group Corporation
Serum Institute of India Pvt. Ltd
MYLAN N.V.
AstraZeneca

第16章付録

The Insight Partners について
用語解説

図表

List Of Tables

Table 1. North America Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 4. North America Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 5. North America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 6. US Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 21. Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 26. Germany Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 31. UK Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 36. France Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. France: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. France Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 39. France Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 40. France Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 41. Italy Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 46. Spain Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
Table 57. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 58. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 59. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
Table 60. Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 61. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 62. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 63. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 64. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 65. Japan Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 66. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 67. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 68. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 69. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 70. China Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 71. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 72. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 73. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 74. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 75. India Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 77. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 78. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 79. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 80. South Korea Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 82. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 83. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 84. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 85. Australia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 87. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 88. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 89. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 90. Rest of Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East & Africa Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 137. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 138. Glossary of Terms, Influenza Vaccines Market

List Of Figures

Figure 1. Influenza Vaccines Market Segmentation
Figure 2. Influenza Vaccines Market Segmentation, by Region
Figure 3. Global Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Influenza Vaccines Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Influenza Vaccines Market, By Geography (USD Million)
Figure 7. Global Influenza Vaccines Market- Leading Country Markets (USD Million)
Figure 8. Global Influenza Vaccines Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 16. Global Influenza Vaccines Market - By Geography Forecasts and Analysis - 2022- 2028
Figure 17. Global Influenza Vaccines Market - Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players In Global Influenza Vaccines Market
Figure 19. Global Influenza Vaccines Market - Comparative Company Analysis
Figure 20. Global Influenza Vaccines Market - Growth Strategy Analysis
Figure 21. Global Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 22. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 25. Powder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Tablets Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Global Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 28. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Global Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 31. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Global Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 34. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. North America: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 41. US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
Figure 45. Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 47. Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
Figure 54. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 56. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 63. Middle East & Africa Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 64. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 65. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 67. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
Figure 70. South and Central America Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 71. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 72. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on North America Countries
Figure 76. Impact of COVID-19 Pandemic on European Countries
Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries
Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 79. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 80. Growth Strategies in the Influenza Vaccine Market, 2021-2028

Product Code: TIPRE00004070

The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a CAGR of 7.4% from 2022 to 2028. Increasing government support to promote influenza vaccination and rising investment by top market players and governments are the major factors boosting the market.

The governments of various states are supporting the promotional activities of vaccination program. For instance, the Australian government gives a free seasonal influenza vaccine to those at risk of influenza-related complications through the National Immunization Program (NIP). By 2022, enough vaccines have been given to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination:

In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic.

In July 2022, Health Minister Audrey Gordon and Long-term Care Minister Scott Johnston announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure more Manitoba people are protected against influenza.

The Victorian government received a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022.

In June 2022, The New Zealand government expanded the access to free flu vaccines, with an additional 800,000 New Zealanders eligible from July 1, 2022. Children aged 3 to 12 years and people with severe mental health or addiction problems can now get a free dose of the flu vaccines.

Taiwan's Centers for Disease Control (Taiwan CDC), and the Ministry of Health and Welfare, organized a media event, titled "Let's Stay Healthy Together" to kick off the 2021 government-funded influenza vaccination program. At the event, Director General Chou, Ambassador Tan, and Hsin Chiang were the first to be vaccinated to encourage eligible people to receive government-funded flu vaccines to get their flu vaccinations as soon as possible following the program.

In September 2019, US President Donald Trump signed an executive order to promote the development of better vaccines to protect against seasonal flu and the potential for pandemic flu outbreaks.

In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination worldwide is driving the influenza vaccines market.

Vaccine Type Insights

Based on the vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment is likely to hold a larger market share in 2022. The same segment is anticipated to register a higher CAGR during the forecast period. The quadrivalent influenza (flu) vaccine protects against 4 influenza viruses, including 2 influenza A viruses and 2 influenza B viruses. All flu vaccines in the US during the 2021-2022 season are quadrivalent vaccines. Different vaccines are approved for different age groups.

Virus Type Insights

Based on virus type, the influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the influenza virus type A segment is because it is the most common form of influenza and can infect animals, although illnesses associated with this type of flu are more common.

Technology Insights

Based on technology, the influenza vaccines market is segmented into egg-based and cell-based. The egg-based segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the egg-based segment is due to its most common method of producing flu vaccines through an egg-based manufacturing process that has been used for more than 70 years.

Route of Administration Insights

Based on route of administration, the influenza vaccines market is segmented into injection and nasal spray. The injection segment is likely to hold a larger market share in 2022. The same segment is expected to register a higher CAGR during the forecast period. The market growth of the injection segment is attributed to the fact that it is the most common method for flu vaccine administration.

Target Group Insights

Based on target group, the global influenza vaccines market is divided into infants, children, adults, and elderly people. The infants segment held larger share of the market in 2021. However, the elderly (geriatric population) segment is expected to grow at the highest growth rate during the forecast period.

International Trade Administration (ITA), Farmindustria-Bain & Company, EFPIA member associations, World Health Organization (WHO), Business Monitor International (BMI), Department of Emergency Medicine, and Indian Journal of Medical Sciences are among the primary and secondary sources referred to while preparing the report on the influenza vaccines market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the influenza vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Influenza Vaccines Market - By Vaccine Type
- 1.3.2 Global Influenza Vaccines Market - By Virus Type
- 1.3.3 Global Influenza Vaccines Market - By Technology
- 1.3.4 Global Influenza Vaccines Market - By Route of Administration
- 1.3.5 Global Influenza Vaccines Market - By Target Group
- 1.3.6 Global Influenza Vaccines Market - By Geography

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Influenza Vaccines Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion

5. Global Influenza Vaccines Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Government Support to Promote Influenza Vaccination
- 5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
- 5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
- 5.3.1 Emerging Economies
5.4 Future Trends
- 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis

6. Influenza Vaccine Market -Global Analysis

6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis
6.2 Global Influenza Vaccines Market, By Geography - Forecasts And Analysis
6.3 Global Influenza Vaccines Market - Market Potential Analysis, By Region
6.4 Company Analysis
- 6.4.1 Market Positioning of Key Players
- 6.4.2 Comparative Company Analysis
6.5 Growth Strategy Analysis
6.6 Performance of Key Players
- 6.6.1 Sanofi
- 6.6.2 SEQIRUS

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

7.1 Overview
7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
- 7.3.1 Overview
- 7.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
- 7.4.1 Overview
- 7.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

8.1 Overview
8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
- 8.3.1 Overview
- 8.3.2 Influenza Virus Type A Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
- 8.4.1 Overview
- 8.4.2 Influenza Virus Type B Market Revenue and Forecast to 2028 (US$ Mn)

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

9.1 Overview
9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-based
- 9.3.1 Overview
- 9.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
- 9.4.1 Overview
- 9.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

10.1 Overview
10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
- 10.3.1 Overview
- 10.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
- 10.4.1 Overview
- 10.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

11.1 Overview
11.2 Global Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.3 Infants
- 11.3.1 Overview
- 11.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
- 11.4.1 Overview
- 11.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
- 11.5.1 Overview
- 11.5.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
- 11.6.1 Overview
- 11.6.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
- 12.1.1 Overview
- 12.1.2 North America: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.3 North America: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
- 12.1.4 North America: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
- 12.1.5 North America: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
- 12.1.6 North America: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
- 12.1.7 North America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
- 12.1.8 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  - 12.1.8.1 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.1.1 Overview
    - 12.1.8.1.2 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.1.8.1.4 US: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.1.8.1.5 US: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.1.8.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.8.1.7 US: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.1.8.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.2.1 Overview
    - 12.1.8.2.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.1.8.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.1.8.2.5 Canada: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.1.8.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.8.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.1.8.3 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.3.1 Overview
    - 12.1.8.3.2 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.8.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.1.8.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.1.8.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.1.8.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.8.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.2 Europe: Influenza Vaccines Market
- 12.2.1 Overview
- 12.2.2 Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
- 12.2.3 Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
- 12.2.4 Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
- 12.2.5 Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
- 12.2.6 Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
- 12.2.7 Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
- 12.2.8 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  - 12.2.8.1 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.1.5 Germany: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.2.8.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.2.1 Overview
    - 12.2.8.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.2.5 UK: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.2.7 UK: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.2.8.3 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.3.1 Overview
    - 12.2.8.3.2 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.3.4 France: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.3.5 France: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.3.7 France: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.2.8.4 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.4.1 Overview
    - 12.2.8.4.2 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.4.5 Italy: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.2.8.5 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.5.5 Spain: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.2.8.6 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.2.8.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    - 12.2.8.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    - 12.2.8.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    - 12.2.8.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.2.8.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.3 Asia Pacific: Influenza Vaccines Market
- 12.3.1 Overview
- 12.3.2 Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
- 12.3.3 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
- 12.3.4 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
- 12.3.5 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
- 12.3.6 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
- 12.3.7 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
- 12.3.8 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  - 12.3.8.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.3.8.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.2.7 China: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.3.8.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.3.7 India: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.3.8.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.3.8.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    - 12.3.8.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.3.8.6 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.3.8.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    - 12.3.8.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    - 12.3.8.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 12.3.8.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    - 12.3.8.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.4 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
- 12.4.1 Overview
- 12.4.2 Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
- 12.4.3 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
- 12.4.4 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
- 12.4.5 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
- 12.4.6 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
- 12.4.7 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
- 12.4.8 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  - 12.4.8.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.4.8.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.4.8.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.4.8.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.4.8.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.4.8.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.4.8.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.4.8.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.4.8.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.4.8.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.4.8.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.4.8.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.4.8.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    - 12.4.8.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.4.8.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.5 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
- 12.5.1 Overview
- 12.5.2 South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
- 12.5.3 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
- 12.5.4 South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
- 12.5.5 South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
- 12.5.6 South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
- 12.5.7 South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
- 12.5.8 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  - 12.5.8.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.5.8.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.5.8.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    - 12.5.8.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.5.8.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.5.8.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.2.1 Overview
    - 12.5.8.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.5.8.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.5.8.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    - 12.5.8.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.5.8.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.5.8.3 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.3.1 Overview
    - 12.5.8.3.2 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.5.8.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.5.8.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.5.8.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    - 12.5.8.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.5.8.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Influenza Vaccine Market -Industry Landscape

14.1 Overview
14.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
14.3 Inorganic Growth Strategies
- 14.3.1 Overview
14.4 Organic Growth Strategies
- 14.4.1 Overview

15. Company Profiles

15.1 Moderna, Inc.
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 SEQIRUS
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Sanofi
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 GlaxoSmithKline plc.
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Hualan Biological Engineering Inc.
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Emergent BioSolutions Inc.
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Mitsubishi Chemical Group Corporation
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Serum Institute of India Pvt. Ltd
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 MYLAN N.V.
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 AstraZeneca
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners
16.2 Glossary of Terms

インフルエンザワクチンの2028年までの市場予測-、ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別の世界的分析

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group

目次

第1章イントロダクション

第2章インフルエンザワクチン市場-主要なポイント

第3章調査手法

第4章インフルエンザワクチン市場- 市場情勢

第5章インフルエンザワクチンの世界市場- 主要な市場力学

第6章インフルエンザワクチン市場-世界分析

第7章インフルエンザワクチン市場の分析と2028年までの予測（ワクチンタイプ別）

第8章インフルエンザワクチン市場の分析と2028年までの予測（ウイルスタイプ別）

第9章インフルエンザワクチン市場の分析と2028年までの予測（技術別）

第10章インフルエンザワクチン市場の分析と2028年までの予測（投与経路別）

第11章インフルエンザワクチン市場の分析と2028年までの予測（対象グループ別）

第12章インフルエンザワクチン市場の分析と2028年までの予測（地域別分析）

第13章 COVID-19パンデミックによるインフルエンザワクチンの世界市場への影響

第14章インフルエンザワクチン市場：業界情勢

第15章企業プロファイル

第16章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

4. Influenza Vaccines Market - Market Landscape

5. Global Influenza Vaccines Market - Key Market Dynamics

6. Influenza Vaccine Market -Global Analysis

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

12. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

14. Influenza Vaccine Market -Industry Landscape

15. Company Profiles

16. Appendix

インフルエンザワクチンの2028年までの市場予測-、ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別の世界的分析

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group

目次

第1章 イントロダクション

第2章 インフルエンザワクチン市場-主要なポイント

第3章 調査手法

第4章 インフルエンザワクチン市場- 市場情勢

第5章 インフルエンザワクチンの世界市場- 主要な市場力学

第6章 インフルエンザワクチン市場-世界分析

第7章 インフルエンザワクチン市場の分析と2028年までの予測（ワクチンタイプ別）

第8章 インフルエンザワクチン市場の分析と2028年までの予測（ウイルスタイプ別）

第9章 インフルエンザワクチン市場の分析と2028年までの予測（技術別）

第10章 インフルエンザワクチン市場の分析と2028年までの予測（投与経路別）

第11章 インフルエンザワクチン市場の分析と2028年までの予測（対象グループ別）

第12章 インフルエンザワクチン市場の分析と2028年までの予測（地域別分析）

第13章 COVID-19パンデミックによるインフルエンザワクチンの世界市場への影響

第14章 インフルエンザワクチン市場：業界情勢

第15章 企業プロファイル

第16章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

4. Influenza Vaccines Market - Market Landscape

5. Global Influenza Vaccines Market - Key Market Dynamics

6. Influenza Vaccine Market -Global Analysis

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

12. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

14. Influenza Vaccine Market -Industry Landscape

15. Company Profiles

16. Appendix

第1章イントロダクション

第2章インフルエンザワクチン市場-主要なポイント

第3章調査手法

第4章インフルエンザワクチン市場- 市場情勢

第5章インフルエンザワクチンの世界市場- 主要な市場力学

第6章インフルエンザワクチン市場-世界分析

第7章インフルエンザワクチン市場の分析と2028年までの予測（ワクチンタイプ別）

第8章インフルエンザワクチン市場の分析と2028年までの予測（ウイルスタイプ別）

第9章インフルエンザワクチン市場の分析と2028年までの予測（技術別）

第10章インフルエンザワクチン市場の分析と2028年までの予測（投与経路別）

第11章インフルエンザワクチン市場の分析と2028年までの予測（対象グループ別）

第12章インフルエンザワクチン市場の分析と2028年までの予測（地域別分析）

第14章インフルエンザワクチン市場：業界情勢

第15章企業プロファイル

第16章付録